[Other] Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1)

vsp_ree Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-29 00:07
Reward30points

Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00967-0/abstract

https://doi.org/10.1016/S0140-6736(26)00967-0

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
cchaiyos Post time 1 hour(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list